Anuh Pharma Intrinsic Value
Anuh Pharma (ANUHPHR) median intrinsic value is ₹90.20 from 9 valuation models (range ₹26–₹158), vs current price ₹79.07 — +14.1% upside (Trading Below Median Value), margin of safety 12.3%. Read ANUHPHR dividend yield for the complete payout history and dividend yield track record.
ANUHPHR Valuation Methods Summary — DCF, Graham Number & P/E
Anuh Pharma intrinsic value across 9 models vs current price ₹79.07 — upside/downside and value range per method. Analyse ANUHPHR shareholding pattern to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹90.20 | ₹72.16 - ₹108.24 | +14.1% | EPS: ₹4.10, Sector P/E: 22x |
| Book Value Method | asset | ₹140.80 | ₹126.72 - ₹154.88 | +78.1% | Book Value/Share: ₹70.40, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹158.14 | ₹142.33 - ₹173.95 | +100.0% | Revenue/Share: ₹154.40, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹124.00 | ₹111.60 - ₹136.40 | +56.8% | EBITDA: ₹62.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹78.54 | ₹62.83 - ₹94.25 | -0.7% | CF Growth: 8.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹26.24 | ₹23.62 - ₹28.86 | -66.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹65.17 | ₹58.65 - ₹71.69 | -17.6% | Revenue Growth: 11.9%, Adj P/E: 15.9x |
| ROE Based Valuation | profitability | ₹93.60 | ₹84.24 - ₹102.96 | +18.4% | ROE: 11.1%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹80.59 | ₹72.53 - ₹88.65 | +1.9% | EPS: ₹4.10, BVPS: ₹70.40 |
ANUHPHR Intrinsic Value vs Market Price — All Valuation Models
Anuh Pharma fair value range ₹26–₹158 vs current market price ₹79.07 across 9 valuation models. For current market price and key ratios, visit ANUHPHR share price.
ANUHPHR Intrinsic Value Analysis — Undervalued or Overvalued?
Anuh Pharma median intrinsic value ₹90.20, current price ₹79.07 — Trading Below Median Value by 14.1%, margin of safety 12.3%.
What is the intrinsic value of ANUHPHR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Anuh Pharma (ANUHPHR) is ₹90.20 (median value). With the current market price of ₹79.07, this represents a +14.1% variance from our estimated fair value.
The valuation range spans from ₹26.24 to ₹158.14, indicating ₹26.24 - ₹158.14.
Is ANUHPHR undervalued or overvalued?
Based on our multi-method analysis, Anuh Pharma (ANUHPHR) appears to be trading below median value by approximately 14.1%.
ANUHPHR Financial Health — Key Ratios vs Industry Benchmarks
Anuh Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 225.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.1% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.39x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ANUHPHR Cash Flow Quality — Operating & Free Cash Flow
Anuh Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹37 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹13 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹54 Cr | ₹32 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹29 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-19 Cr | ₹-19 Cr | Negative Cash Flow | 3/10 |